Will 100 be the next 60? A $250 million stem cell company that has raised the money could help extend life expectancy
Investments in longevity are the hottest investment targets;
Startups founded just 5 months ago have raised $250 million.
The company, which was founded in September in Warren, New Jersey, announced on Thursday that it had raised $250 million from the global biopharmaceutical firm Celgene, United Therapeutics Corporation, Sorrento Therapeutics, and Human Longevity, Inc., a DNA sequencing and machine-learning company.
The company’s \”Band-Aids\”, which are biological, can be used to treat wounds or burns caused by injury or reconstructive surgery. Its stem cell injectable products can also accelerate the repair of tissue or organs. According to Hariri, these restorative products range from a few hundred dollars to a couple thousand dollars per unit. Celularity acquired Alliqua BioMedical in January for $29 millions, and bought the stem cell bandage division.
Source:
https://www.cnbc.com/2018/02/15/peter-diamandis-celularity-could-help-cure-cancer-extend-lifespans.html?__source=sharebar|facebook&par=sharebar
